Jean Bousquet Selected Research

BNT162 Vaccine

3/2023	COVID-19 after BNT162b2 two-dose primary series does not improve the efficacy of a booster dose in nursing home residents.
12/2022	Antibody response after first and second BNT162b2 vaccination to predict the need for subsequent injections in nursing home residents.
10/2022	Amplitudes and kinetic of antibodies after second and third doses of BNT162b2 vaccine in nonagenarians and centenarians with and without prior SARS-CoV-2 infection.
1/2022	Receptor binding domain-IgG levels correlate with protection in residents facing SARS-CoV-2 B.1.1.7 outbreaks.
1/2022	Antibody response after one and two jabs of the BNT162b2 vaccine in nursing home residents: The CONsort-19 study.
4/2021	Spike Antibody Levels of Nursing Home Residents With or Without Prior COVID-19 3 Weeks After a Single BNT162b2 Vaccine Dose.
1/2021	ARIA-EAACI statement on severe allergic reactions to COVID-19 vaccines - An EAACI-ARIA Position Paper.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jean Bousquet Research Topics

Disease

117	Asthma (Bronchial Asthma) 05/2024 - 01/2002
58	Allergic Rhinitis 05/2024 - 01/2004
52	Hypersensitivity (Allergy) 05/2024 - 01/2004
37	Rhinitis 12/2023 - 01/2004
22	COVID-19 03/2023 - 01/2020
11	Seasonal Allergic Rhinitis (Hay Fever) 03/2022 - 03/2004
10	Inflammation (Inflammations) 05/2011 - 06/2002
9	Chronic Obstructive Pulmonary Disease (COPD) 01/2019 - 05/2003
8	Infections 08/2023 - 01/2006
7	Anaphylaxis (Anaphylactic Shock) 12/2022 - 12/2019
7	Food Hypersensitivity (Food Allergy) 01/2021 - 10/2013
6	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2023 - 09/2009
5	Perennial Allergic Rhinitis 11/2023 - 03/2005
5	Nasal Polyps (Nasal Polyp) 08/2023 - 11/2010
4	Rhinosinusitis 01/2022 - 09/2009
4	Eczema 01/2021 - 02/2014
3	Drug Hypersensitivity (Drug Allergy) 12/2022 - 12/2019
3	Cough 05/2022 - 12/2020
3	Chronic Cough 05/2022 - 10/2009
3	Atopic Dermatitis (Atopic Eczema) 11/2020 - 11/2006
3	Virus Diseases (Viral Diseases) 01/2020 - 01/2006
2	Conjunctivitis 11/2023 - 01/2019
2	Eosinophilia 08/2022 - 03/2005
2	Sinusitis 01/2022 - 04/2011
2	Cytokine Release Syndrome 12/2020 - 11/2020
2	Chronic Disease (Chronic Diseases) 12/2020 - 04/2011
2	Neoplasms (Cancer) 11/2019 - 01/2019
2	Allergic Conjunctivitis (Giant Papillary Conjunctivitis) 05/2019 - 01/2019

Drug/Important Bio-Agent (IBA)

46	AllergensIBA 10/2023 - 08/2002
37	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2024 - 01/2002
30	Immunoglobulin E (IgE)IBA 04/2024 - 01/2004
16	Fluticasone (Cutivate)FDA LinkGeneric 10/2022 - 01/2002
13	Proteins (Proteins, Gene)FDA Link 12/2023 - 11/2010
11	VaccinesIBA 12/2022 - 01/2004
9	Omalizumab (Xolair)FDA Link 08/2022 - 04/2004
9	Salmeterol Xinafoate (Serevent)FDA Link 01/2019 - 10/2003
8	Biomarkers (Surrogate Marker)IBA 05/2024 - 06/2003
8	azelastine (Optivar)FDA LinkGeneric 01/2023 - 05/2012
7	BNT162 VaccineIBA 03/2023 - 01/2021
7	AntibodiesIBA 10/2022 - 11/2010
7	Nitric Oxide (Nitrogen Monoxide)FDA Link 05/2022 - 06/2003
6	Histamine Antagonists (Antihistamines)IBA 04/2024 - 02/2005
5	CytokinesIBA 12/2023 - 03/2002
5	Monoclonal AntibodiesIBA 01/2022 - 12/2008
5	Air Pollutants (Pollutants, Air)IBA 12/2021 - 01/2020
5	Bronchodilator Agents (Bronchodilators)IBA 01/2019 - 01/2002
5	SteroidsIBA 08/2012 - 06/2003
5	Interleukin-8 (Interleukin 8)IBA 12/2009 - 06/2002
5	GlucocorticoidsIBA 01/2005 - 01/2002
4	Enterotoxins (Enterotoxin)IBA 10/2023 - 11/2010
4	SmokeIBA 08/2023 - 11/2008
4	Tobacco Smoke Pollution (Passive Smoking)IBA 08/2023 - 10/2009
4	Immunoglobulin G (IgG)IBA 12/2022 - 11/2021
4	TabletsIBA 03/2022 - 01/2011
4	anti-IgE antibodiesIBA 12/2019 - 04/2004
4	Anti-Bacterial Agents (Antibiotics)IBA 01/2018 - 02/2005
4	MP29-02IBA 01/2016 - 05/2012
4	NF-kappa B (NF-kB)IBA 12/2009 - 06/2003
4	montelukast (Singulair)FDA Link 06/2009 - 01/2002
3	Formoterol Fumarate (Oxis)FDA Link 08/2023 - 12/2007
3	mepolizumabIBA 10/2022 - 01/2022
3	SolutionsIBA 01/2022 - 06/2018
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022 - 01/2002
3	ORALIT (ORS)IBA 12/2021 - 09/2012
3	Oxygen (Dioxygen)IBA 01/2021 - 12/2020
3	Particulate MatterIBA 11/2020 - 12/2015
3	Environmental Pollutants (Pollutants, Environmental)IBA 03/2020 - 04/2017
3	ragweed pollenIBA 01/2019 - 01/2018
3	Fluticasone-Salmeterol Drug Combination (Advair)FDA Link 04/2017 - 12/2007
3	desloratadine (Aerius)FDA LinkGeneric 05/2013 - 01/2010
3	Beclomethasone (Beclometasone)FDA Link 03/2012 - 01/2002
3	Leukotriene Antagonists (Leukotriene Receptor Antagonists)IBA 06/2009 - 01/2002
3	levocetirizine FDA LinkGeneric 10/2006 - 10/2004
2	Epinephrine (Adrenaline)FDA LinkGeneric 12/2022 - 01/2021
2	Arthropod VenomsIBA 12/2022 - 01/2020
2	Antitussive Agents (Antitussives)FDA Link 05/2022 - 02/2005
2	Transcription Factors (Transcription Factor)IBA 03/2022 - 01/2014
2	CurcuminIBA 03/2022 - 12/2020
2	AnkyrinsIBA 03/2022 - 01/2021
2	AntioxidantsIBA 03/2022 - 01/2021
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2022 - 07/2020
2	SootIBA 12/2021 - 12/2015
2	LipidsIBA 11/2021 - 01/2005
2	COVID-19 VaccinesIBA 10/2021 - 01/2021
2	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 01/2018
2	Nitrogen DioxideIBA 11/2020 - 12/2015
2	rupatadineIBA 01/2020 - 01/2019
2	Indicators and Reagents (Reagents)IBA 01/2020 - 12/2015
2	P-2 (P 2)IBA 01/2018 - 11/2008
2	Interleukin-5 (Interleukin 5)IBA 11/2010 - 11/2006
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2009 - 03/2002
2	Budesonide (Pulmicort)FDA LinkGeneric 12/2007 - 01/2002

Therapy/Procedure

27	Therapeutics 10/2022 - 03/2004
18	Immunotherapy 01/2023 - 12/2007
8	Drug Therapy (Chemotherapy) 11/2022 - 02/2005
5	Home Nursing (Nursing, Home) 03/2023 - 07/2020
3	Precision Medicine 01/2023 - 01/2017
3	Injections 12/2022 - 10/2021
3	Self Medication 04/2019 - 01/2019
2	Long-Term Care 12/2020 - 12/2020